Back

Prevention of contrast-induced nephropathy with renalguard system in patients at high and very-high risk, undergoing transcatheter aortic valve implantation

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Non-coronary cardiac interventions and more Non coronary cardiac interventions ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Diego Lopez Otero

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

19 More presentations in this session

Presentation thumbnail
Transcatheter pulmonary valve implantation following the ross procedure - a single center experience
Doctor K. Alassas (Awali, BH)
Presentation thumbnail
Prolongation of neurohumoral activation in patients with chronic right ventricular pacing after pacemaker implantation following transfemoral aortic valve implantation (TAVI)
Miss C. Marzahn (Bernau bei Berlin, DE)
Abstract
Presentation thumbnail
Impact of closure devices in TAVI procedures on vascular complications and mortality
Associate Professor Z. Dimitriadis (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Changes in left atrial reservoir- and conduit function after interventional closure of the left atrial appendage in patients with atrial fibrillation
Associate Professor B. Luani (Ingolstadt, DE)
Abstract Slides
Presentation thumbnail
Improvement of success rate by percutaneous left atrial appendage closure in 259 patients with 3 types of occluder and clinical follow-up over 4 years
Doctor J. Yu (Koblenz, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 6 - Non-coronary cardiac interventions and more

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources